ONCOLYTICS BIOTECH INC's ticker is ONCY and the CUSIP is 682310875. A total of 36 filers reported holding ONCOLYTICS BIOTECH INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26 | -16.1% | 11,900 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $31 | +121.4% | 11,900 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $14 | -26.3% | 11,900 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $19 | -99.9% | 11,900 | +5.6% | 0.00% | 0.0% |
| Q3 2022 | $15,000 | +36.4% | 11,268 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $11,000 | -38.9% | 11,268 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $18,000 | +12.5% | 11,268 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $16,000 | -33.3% | 11,268 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $24,000 | -22.6% | 11,268 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $31,000 | -26.2% | 11,268 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $42,000 | +1300.0% | 11,268 | +723.7% | 0.00% | – |
| Q4 2020 | $3,000 | +50.0% | 1,368 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | – | 1,368 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 5,302,036 | $11,558,438 | 2.33% |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 201,453 | $449,240 | 0.06% |
| BRAVE ASSET MANAGEMENT INC | 25,000 | $54,927 | 0.02% |
| Ausdal Financial Partners, Inc. | 20,000 | $43,600 | 0.01% |
| HEADINVEST, LLC | 11,534 | $24,106 | 0.01% |
| Cedar Mountain Advisors, LLC | 5,651 | $12,319 | 0.00% |
| Long Focus Capital Management, LLC | 40,000 | $87,200 | 0.00% |
| Banque Cantonale Vaudoise | 11,900 | $26 | 0.00% |
| OSAIC HOLDINGS, INC. | 9,712 | $21,173 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 33,485 | $72,997 | 0.00% |